Cargando…
Combined analysis of serum γ-glutamyl transferase isoenzyme II, α-L-fucosidase and α-fetoprotein detected using a commercial kit in the diagnosis of hepatocellular carcinoma
γ-glutamyl transferase isoenzyme II (GGT-II) is a sensitive biomarker of hepatocellular carcinoma (HCC). However, numerous disadvantages of the traditional manual method affected its application. The commercial kit provided a convenient and fast method for the determination of GGT-II levels. The pur...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3524245/ https://www.ncbi.nlm.nih.gov/pubmed/23251247 http://dx.doi.org/10.3892/etm.2012.783 |
_version_ | 1782253299100024832 |
---|---|
author | ZHU, JING JIANG, FENG NI, HONG-BING XIAO, MING-BING CHEN, BU-YOU NI, WEN-KAI LU, CUI-HUA NI, RUN-ZHOU |
author_facet | ZHU, JING JIANG, FENG NI, HONG-BING XIAO, MING-BING CHEN, BU-YOU NI, WEN-KAI LU, CUI-HUA NI, RUN-ZHOU |
author_sort | ZHU, JING |
collection | PubMed |
description | γ-glutamyl transferase isoenzyme II (GGT-II) is a sensitive biomarker of hepatocellular carcinoma (HCC). However, numerous disadvantages of the traditional manual method affected its application. The commercial kit provided a convenient and fast method for the determination of GGT-II levels. The purposes of the present study were to compare the reproducibility and sensitivity between the manual and commercial kit methods and to evaluate the diagnostic efficiency for HCC with the combined analysis of GGT-II, α-L-fucosidase (AFU) and α-fetoprotein (AFP). In patients with various liver diseases (HCC, liver cirrhosis and chronic hepatitis) and normal subjects, GGT-II was detected by manual and commercial polyacrylamide gel electrophoresis (PAGE). The levels of AFU and AFP were assayed by colorimetry and a chemiluminescence immunoassay, respectively. The commercial PAGE had equal diagnostic efficiency with traditional manual PAGE and no significant differences were observed in intra- and average-gel reproducibility and GGT-II sensitivities between the manual and commercial PAGE (P>0.05). The incidence of GGT-II detected by commercial PAGE in HCC patients was 84.1% and <8% in benign liver disease. The levels of AFU and AFP in the benign liver diseases and normal subjects were lower than those in HCC. According to the cut-off value obtained by receiver operating characteristic curves, a total of 56.6 and 59.3% of HCC patients (64 out of 113 and 67 out of 113) had AFU >636.5 μmol/l h and AFP >44.0 μg/l, respectively. There were no significant correlations between GGT-II and AFU or AFP. Combined detection of GGT-II with AFU or AFP increased the diagnostic sensitivity to 92.9 and 93.8%, respectively. These results suggest that commercial PAGE provides a simple and reproducible method for GGT-II detection. Combined determination of GGT-II with AFU or AFP exhibited superior sensitivity and specificity for the diagnosis of HCC. |
format | Online Article Text |
id | pubmed-3524245 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | D.A. Spandidos |
record_format | MEDLINE/PubMed |
spelling | pubmed-35242452012-12-18 Combined analysis of serum γ-glutamyl transferase isoenzyme II, α-L-fucosidase and α-fetoprotein detected using a commercial kit in the diagnosis of hepatocellular carcinoma ZHU, JING JIANG, FENG NI, HONG-BING XIAO, MING-BING CHEN, BU-YOU NI, WEN-KAI LU, CUI-HUA NI, RUN-ZHOU Exp Ther Med Articles γ-glutamyl transferase isoenzyme II (GGT-II) is a sensitive biomarker of hepatocellular carcinoma (HCC). However, numerous disadvantages of the traditional manual method affected its application. The commercial kit provided a convenient and fast method for the determination of GGT-II levels. The purposes of the present study were to compare the reproducibility and sensitivity between the manual and commercial kit methods and to evaluate the diagnostic efficiency for HCC with the combined analysis of GGT-II, α-L-fucosidase (AFU) and α-fetoprotein (AFP). In patients with various liver diseases (HCC, liver cirrhosis and chronic hepatitis) and normal subjects, GGT-II was detected by manual and commercial polyacrylamide gel electrophoresis (PAGE). The levels of AFU and AFP were assayed by colorimetry and a chemiluminescence immunoassay, respectively. The commercial PAGE had equal diagnostic efficiency with traditional manual PAGE and no significant differences were observed in intra- and average-gel reproducibility and GGT-II sensitivities between the manual and commercial PAGE (P>0.05). The incidence of GGT-II detected by commercial PAGE in HCC patients was 84.1% and <8% in benign liver disease. The levels of AFU and AFP in the benign liver diseases and normal subjects were lower than those in HCC. According to the cut-off value obtained by receiver operating characteristic curves, a total of 56.6 and 59.3% of HCC patients (64 out of 113 and 67 out of 113) had AFU >636.5 μmol/l h and AFP >44.0 μg/l, respectively. There were no significant correlations between GGT-II and AFU or AFP. Combined detection of GGT-II with AFU or AFP increased the diagnostic sensitivity to 92.9 and 93.8%, respectively. These results suggest that commercial PAGE provides a simple and reproducible method for GGT-II detection. Combined determination of GGT-II with AFU or AFP exhibited superior sensitivity and specificity for the diagnosis of HCC. D.A. Spandidos 2013-01 2012-10-31 /pmc/articles/PMC3524245/ /pubmed/23251247 http://dx.doi.org/10.3892/etm.2012.783 Text en Copyright © 2013, Spandidos Publications http://creativecommons.org/licenses/by/3.0 This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited. |
spellingShingle | Articles ZHU, JING JIANG, FENG NI, HONG-BING XIAO, MING-BING CHEN, BU-YOU NI, WEN-KAI LU, CUI-HUA NI, RUN-ZHOU Combined analysis of serum γ-glutamyl transferase isoenzyme II, α-L-fucosidase and α-fetoprotein detected using a commercial kit in the diagnosis of hepatocellular carcinoma |
title | Combined analysis of serum γ-glutamyl transferase isoenzyme II, α-L-fucosidase and α-fetoprotein detected using a commercial kit in the diagnosis of hepatocellular carcinoma |
title_full | Combined analysis of serum γ-glutamyl transferase isoenzyme II, α-L-fucosidase and α-fetoprotein detected using a commercial kit in the diagnosis of hepatocellular carcinoma |
title_fullStr | Combined analysis of serum γ-glutamyl transferase isoenzyme II, α-L-fucosidase and α-fetoprotein detected using a commercial kit in the diagnosis of hepatocellular carcinoma |
title_full_unstemmed | Combined analysis of serum γ-glutamyl transferase isoenzyme II, α-L-fucosidase and α-fetoprotein detected using a commercial kit in the diagnosis of hepatocellular carcinoma |
title_short | Combined analysis of serum γ-glutamyl transferase isoenzyme II, α-L-fucosidase and α-fetoprotein detected using a commercial kit in the diagnosis of hepatocellular carcinoma |
title_sort | combined analysis of serum γ-glutamyl transferase isoenzyme ii, α-l-fucosidase and α-fetoprotein detected using a commercial kit in the diagnosis of hepatocellular carcinoma |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3524245/ https://www.ncbi.nlm.nih.gov/pubmed/23251247 http://dx.doi.org/10.3892/etm.2012.783 |
work_keys_str_mv | AT zhujing combinedanalysisofserumgglutamyltransferaseisoenzymeiialfucosidaseandafetoproteindetectedusingacommercialkitinthediagnosisofhepatocellularcarcinoma AT jiangfeng combinedanalysisofserumgglutamyltransferaseisoenzymeiialfucosidaseandafetoproteindetectedusingacommercialkitinthediagnosisofhepatocellularcarcinoma AT nihongbing combinedanalysisofserumgglutamyltransferaseisoenzymeiialfucosidaseandafetoproteindetectedusingacommercialkitinthediagnosisofhepatocellularcarcinoma AT xiaomingbing combinedanalysisofserumgglutamyltransferaseisoenzymeiialfucosidaseandafetoproteindetectedusingacommercialkitinthediagnosisofhepatocellularcarcinoma AT chenbuyou combinedanalysisofserumgglutamyltransferaseisoenzymeiialfucosidaseandafetoproteindetectedusingacommercialkitinthediagnosisofhepatocellularcarcinoma AT niwenkai combinedanalysisofserumgglutamyltransferaseisoenzymeiialfucosidaseandafetoproteindetectedusingacommercialkitinthediagnosisofhepatocellularcarcinoma AT lucuihua combinedanalysisofserumgglutamyltransferaseisoenzymeiialfucosidaseandafetoproteindetectedusingacommercialkitinthediagnosisofhepatocellularcarcinoma AT nirunzhou combinedanalysisofserumgglutamyltransferaseisoenzymeiialfucosidaseandafetoproteindetectedusingacommercialkitinthediagnosisofhepatocellularcarcinoma |